Global Microfluidic Market for Healthcare Application 2016-2020

Global Microfluidic Market for Healthcare Application 2016-2020

Category : Healthcare
Sub Category : Healthcare IT
Published On : July  2016
Pages : 58



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Microfluidics technology

Microfluidics technology deals with the research and development of micro-scale devices, which are capable of handling small amounts of fluids. These devices are used in the healthcare sector to dispense the exact volume of fluids for research, drug development, and drug delivery. Microfluidic devices can also be used to monitor patient health status, ensuring early detection and treatment of diseases. The advantages of these devices are their compact size, low power consumption, cost efficiency, and high functionality.

Technavio’s analysts forecast the global microfluidic market for healthcare application to grow at a CAGR of 17.59% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global microfluidic market for healthcare application for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of microfluidic devices and technology.

The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA

Technavio's report, Global Microfluidic Market for Healthcare Application 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
• Abbott Laboratories
• Agilent Technologies
• Becton Dickinson and Company
• Bio-Rad Laboratories
• RainDance Technologies
• Roche Diagnostics
• Siemens Healthcare GmbH

Other prominent vendors 
• Biocartis
• Biofluidix
• Cepheid
• Danaher
• Fluidigm
• Great Basin
• Life Technologies
• Oxford Nanopore
• PerkinElmer
• Tear Lab
• Thermo Fisher Scientific

Market driver 
• Rapid increase in elderly population and age-related diseases 
• For a full, detailed list, view our report 

Market challenge 
• Low margins for companies in the microfluidic value chain
• For a full, detailed list, view our report 

Market trend 
• Use of paper-based microfluidic devices
• For a full, detailed list, view our report 

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors? 

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Report overview
• Key vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Technology landscape
• Microfluidic systems
PART 06: Market landscape
• Industry overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by application
• End-user applications of microfluidics in healthcare 2015
• End-user applications of microfluidics in healthcare 2020
• In-vitro diagnostics using microfluidics
• Pharmaceutical research using microfluidics
• Drug delivery devices using microfluidics
PART 08: Geographical segmentation
• Regional segregation 2015
• Regional segregation 2020
• Americas
• EMEA
• APAC
PART 09: Market drivers
• Compact size of microfluidic devices
• Growth in lifestyle diseases
• Increase in research funding and government participation
• Rapid increase in elderly population and age-related diseases
• Higher throughput and reduced reaction cost
PART 10: Impact of drivers
PART 11: Market challenges
• High penetration of traditional healthcare equipment
• Low margins for companies in the microfluidic value chain
• Lack of awareness about microfluidics
• Reliability issues
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Use of paper-based microfluidic devices
• Growth in POC testing
PART 14: Vendor landscape
• Competitive scenario
PART 15: Key vendors
• Abbott Laboratories
• Agilent Technologies
• Becton Dickinson
• Bio-Rad Laboratories
• RainDance Technologies
• Roche Diagnostics
• Siemens Healthcare
• Other prominent vendors
PART 16: Key recommendations for vendors and investors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Steps of a typical microfluidic process
Exhibit 03: Market segmentation of microfluidics in healthcare
Exhibit 04: Global microfluidic market for healthcare application 2016-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Percentage segregation of microfluidics for application in healthcare sector 2015
Exhibit 07: Percentage segregation of microfluidics for application in healthcare sector 2020
Exhibit 08: Global microfluidic market for in-vitro diagnostics in healthcare 2015-2020 ($ billions)
Exhibit 09: Global microfluidic market in pharmaceutical research for healthcare 2015-2020 ($ billions)
Exhibit 10: Global microfluidic market in drug delivery devices for healthcare 2015-2020 ($ millions)
Exhibit 11: Geographical share in percentage 2015
Exhibit 12: Geographical share in percentage 2020
Exhibit 13: Global microfluidic market for healthcare application in Americas 2016-2020 ($ billions)
Exhibit 14: Global microfluidic market for healthcare application in EMEA 2015-2020 ($ billions)
Exhibit 15: Global microfluidic market for healthcare application in APAC 2015-2020 ($ millions)
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Overview of major players in the global microfluidic market for healthcare application 2015
Exhibit 19: Recent developments: Abbott Laboratories
Exhibit 20: Sector performance
Exhibit 21: Capital expenditure
Exhibit 22: Segment performance
Exhibit 23: Capital expenditure
Exhibit 24: Siemens Healthcare: Business segmentation
Exhibit 25: Recent developments: Siemens Healthcare
Exhibit 26: Other prominent vendors

Enquiry Before Buy
image
Can´t read the image ? refresh here.